Sevag Demirjian, MD: Improving Dialysis for ICU Patients

Video

Dr. Demirjian explained suggested changes to how dialysis is conducted in hospital settings.

A new analysis of patients in the intensive care unit (ICU) showed small solute clearance represented by urea reduction ratio (URR) was higher in dialysis treatments with dialysate flow rates of 300 compared to 600 mL/min.

A team, led by Sevag Demirjian, MD, Cleveland Clinic, presented new data during the 2022 American Society of Nephrology (ASN) Annual Meeting in Orlando how patients requiring bedside intermittent dialysis.

The study included dialysis treatments with prescribed and completed 4 hour treatments with achieved blood flow rate of 400 ml/min.

The results show the mean URR was significantly different between the dialysate flow rate 300/F160 and dialysate flow rate 600/F160 groups (.69 vs .72; P = .03). However the mean URR was similar between dialysate flow rate 300/F250 and dialysate flow rate 600/F160 (.71 vs .72; P = .17).

The difference was likely offset by the use of larger dialyzer.

In an interview with HCPLive®, Demirjian explained why the findings were crucial and could drive better decisions regarding dialysis in a hospital setting.

He also discussed how dialysis is being used currently in hospital settings and whether there needs to be changes made to the process.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.